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HISTORY 
A  46 year old  woman  presented  with  a  painless 
palpable mass in the left breast for two weeks. She had 
no  nipple  discharge  and  no  familial  history  of  breast 
carcinoma.  Physical  examination  revealed  a  4.5 cm 
circumscribed,  movable  mass  in  the  left  upper  outer 
quadrant. The overlying skin was normal. The axillary 
lymph node was not enlarged.  
IMAGING FINDINGS 
Mammograms  revealed  a  4.5  cm,  well 
circumscribed mass without calcification at 3 o’clock in 
the left breast (Figure 1). Ultrasonography (US) revealed 
a  circumscribed,  macro  lobulated  mass  with 
heterogenous  internal  echoes  and  a  slight  posterior 
acoustic enhancement (Figure 2).  
CLINICAL COURSE 
Fine needle aspiration biopsy (FNAB) of the mass 
showed  benign  epithelial  cells  which  could  be  either 
fibroadenoma  or  phyllodes  tumour.  The  patient 
underwent  a  wide  excision  of  the  mass.  She  made  an 
uneventful  recovery,  and  a  simple  mastectomy  was 
planned. 
PATHOLOGICAL FINDINGS 
At  gross  examination,  the  specimen  contained  a 
circumscribed mass measuring 4.5 cm in diameter with 
grayish white  trabeculated  cut  surface  (Figure  3). 
Microscopic examination revealed long attenuated ducts 
among cellular stroma with circumscribed border (Figure 
4a). The stroma consisted of spindle shaped cells with 
elongated plump nuclei. Some nuclei were pleomorphic 
(Figure 4b). Mitotic figures were occasionally observed, 
approximately  more  than  5  mitoses  per  high powered 
field  on  average.  These  findings  were  consistent  with 
malignant phyllodes tumour. 
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DISCUSSION 
Phyllodes tumour, previously described by Johannes 
Muller in 1838 as cystosarcoma phyllodes [1], accounts 
for  less  than  1%  of  mammary  tumours  and  represents 
approximately 2% 3% of fibroepithelial tumours of the 
breast [2]. Phyllodes tumour is composed of epithelial 
elements and a connective tissue similar to fibroadenoma 
but phyllodes tumour has higher stromal cellularity. The 
tumour usually occurs among women 40 50 years old [3] 
whereas fibroadenoma is common in women 20 30 years 
old  [2].  Clinically,  patients  present  with  a  palpable, 
painless, slow growing mass, that can reach a large size 
suddenly [4 6]. Occasionally, ulceration of the skin may 
occur  due  to  stretching  over  the  large  tumour.  On 
mammography, phyllodes tumour is seen as a lobulated, 
round, or oval circumscribed mass without calcification. 
On  US,  phyllodes  tumour  usually  appears  as  a  well 
defined  mass  with  heterogenous  internal  echoes  and 
sometimes having posterior acoustic enhancement [4 8]. 
The presence of fluid filled, elongated spaces or clefts 
(Figure 5) within a solid mass is suggestive of phyllodes 
tumour  but  not  pathognomonic  of  the  diagnosis  [5,6]. 
Liberman et al [7] reported that a phyllodes tumour with 
diameter greater than 3 cm tended to be associated with 
malignancy.  However,  there  are  no  reliable 
mammographic  or  US  features  to  differentiate  benign 
from  malignant  phyllodes  tumour  [4 6,8]  (Figure  6). 
Differentiation of phyllodes tumour from fibroadenoma 
by  mammographic  and  US  features  is  difficult  but 
important  because  of  difference  in  management  [3,5]. 
Fibroadenoma may regress spontaneously so follow up 
in selected women such as those who are young without 
high risk of breast cancer, pregnant or refuse surgery is 
possible  [3].  Whereas,  phyllodes  tumour  requires 
complete  surgical  removal  of  the  mass  with  wide 
margins. 
Preoperative  diagnosis  of  phyllodes  tumour  with 
FNAB  is  controversial  because  fibroadenoma  is 
frequently  diagnosed  due  to  the  substantial  cytologic 
overlap  similar  to  our  presented.  Occasionally,  false 
positive  diagnosis  of  carcinoma  is  also  made  [4,5]. 
Multiple samplings are required for a correct diagnosis 
because phyllodes tumour is often heterogeneous. Since 
it  is  difficult  to  differentiate  fibroadenoma  from 
phyllodes  tumour  on  imaging  features  and  cytology, 
histological examination should be conducted to confirm 
the diagnosis. The distinction between them bases solely 
 
(a) 
 
(b) 
Figure 1  (a) Mediolateral oblique and (b) craniocaudal mammograms show a heterogeneously dense breast with 
a round, well circumscribed, 4.5 cm mass at 3 o’clock in the left breast. 
 
 
Figure 2  Transverse US image shows a circumscribed, lobulated 
mass with heterogeneous internal echoes and a slight 
posterior acoustic enhancement (arrows). 
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Figure 4  (a)  Photomicrograph  shows circumscribed  border of  tumour  (arrows)  (Haematoxylin &  eosin  stain, 
X40); (b) Photomicrograph shows spindle cells with plump nuclei (arrow). Mitosis (double arrows) is 
also noted. (Haematoxylin & eosin stain, X400). 
 
 
 
 
 
 
 
(a) 
 
(b) 
Figure 5  Benign phyllodes tumour in a 35 year old woman. (a) Transverse US image shows a circumscribed 
heterogenous  echo  with  a  small  cystic  space  (arrow)  and  a  slight  posterior  acoustic  enhancement; 
(b) Photomicrograph  shows  leaf like  processes  containing  cellular  stroma  lined  with  benign  ductal 
epithelial cells projecting into the cystic space (haematoxylin & eosin stain; x100). 
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on  the  histologic  features  of  stroma  [5].  Phyllodes 
tumour  may  be  classified  as  benign,  borderline  or 
malignant  [6,7].  Although  phyllodes  tumour  is  usually 
benign,  approximately  20 50%  are  malignant. 
Histological indications of malignancy include increased 
mitotic  activity,  pronounced  proliferation  of  stromal 
components  relative  to  glandular  structures,  cytologic 
atypia, and invasive peripheral growth with infiltration 
into  adjacent  tissues  [6].  Distant  metastases  occur  less 
than  20%,  mainly  in  malignant  phyllodes  tumour  but 
have  also  been  reported  in  benign  ones  [4,6,7]. 
Metastatic  tumour  spread  is  primarily  haematogenous, 
most commonly to lung, pleura and bone. Fewer than 1% 
of malignant phyllodes tumour spread to axillary lymph 
node [9]. 
Treatment  of  phyllodes  tumour  requires  complete 
removal of the tumour with wide margins if the tumour 
is  small  and  a  simple  mastectomy  may  require  if  the 
tumour  is  large.  Local  recurrence  occurs  in 
approximately  20%  of  cases  if  the  tumour  is 
incompletely  excised  [3,7].  Routine  axillary  node 
dissection  does  not  appear  to  be  indicated  [10].  A 
combination of surgery, radiation therapy, chemotherapy, 
and even hormonal therapy is controversial for malignant 
phyllodes tumour [5]. 
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Figure 3  Photograph of an excised specimen shows a well circumscribed, macrolobulated mass with greyish 
white trabeculated cut surface. 
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Figure 6  Benign  phyllodes  tumour  in  a  48 year old  woman.  Left  craniocaudal  mammogram  shows  a  6 cm 
lobulated, circumscribed mass in the inner quadrant. 
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